Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.

Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prev Res (Phila). 2012 Apr; 5(4):544-52.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.